XML 52 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
INTANGIBLE ASSETS (Details) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Gross Carrying Amount $ 3,371,888 $ 2,606,598
Net Amount 3,099,747 2,405,972
Finite-Lived Intangible Assets    
Accumulated Amortization (272,141) (200,626)
Hormone Therapy Drug Candidate Patents - (Pending) [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 1,721,305 1,203,987
Net Amount 1,721,305 1,203,987
Multiple Trademarks [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 233,275 185,465
Net Amount 233,275 185,465
Opera Software Patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (8,487) (6,490)
Net Amount $ 23,464 $ 25,461
Weighted average remaining amortization period 11 years 9 months 12 years 9 months
Development Costs Of Corporate Website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization (91,743) (91,743)
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 1,293,614 1,093,452
Accumulated Amortization (171,911) (102,393)
Net Amount $ 1,121,703 $ 991,059
Weighted average remaining amortization period 15 years 16 years